Developing new RNA vaccine formulations to target non-enveloped viruses and boost mucosal responses

Vaccine Insights 2024; 3(6), 207–215

DOI: 10.18609/vac.2024.033

Published: 10 October
Interview
Jesse Erasmus



Jesse Erasmus, Director of Virology, HDT Bio, joins Charlotte Barker, Commissioning Editor, Vaccine Insights, to discuss developing an RNA vaccine for enterovirus D68, leveraging mucosal immunity, and strategies for improving tolerability in RNA vaccine formulations.